What challenges do you see with your asthma patients? This was the subject of Dr Lily Higgins’ session at the American Lung Association’s LUNGFORCE Expo 2019. See what challenges were discussed here.
COPD affects more than 16 million Americans. During his session at the American Lung Association’s LUNGFORCE Expo, Andrew Berman, MD, discussed pharmacologic and nonpharmacologic therapy options for...
In a new study, researchers evaluated the effects of triple therapy containing an inhaled glucocorticoid, a LAMA, and a LABA vs dual therapies for reducing exacerbations in more than 10,000 patients with...
Pulmonary rehabilitation requires special facilities, is often costly, and can be difficult to access, whereas Tai Chi requires no special equipment and is increasingly popular worldwide. In a new study,...
Combination treatment with long-acting bronchodilators is recommended for the reduction of COPD exacerbations. In a multicenter cohort of 7880 patients from various countries, researchers compared the...
Following a recent study of 22,130 adult patients with mild to moderate asthma or severe asthma, researchers have pinpointed the risk factors for exacerbation in both patient populations.
Obesity was found to be an independent risk factor for severe disease in hospitalized adults during the 2009 H1N1 influenza pandemic. With this in mind, researchers investigated whether weight also...
The authors of a recent study compared the effects of a LABA-LAMA treatment combination with placebo on cardiac function in patients with chronic obstructive pulmonary disease and lung hyperinflation.
The authors of a new study recently compared 2 inhaled treatment combinations for the treatment of moderate to severe exacerbations in patients with chronic obstructive pulmonary disease.
